| Human Fibroblast Growth Factor 17 (FGF17) Protein , Recombinant |
| Catalog #: P01F0008 |
Other Names
FGF-13; FGF-17; HH20
Background
FGF17 is a member of fibroblast growth factor family It is mainly located in the developing brain tissue. This protein is expressed during embryogenesis and in the adult cerebellum and cortex. FGF17 is an irreplaceable cytokine and has a variety of biological functions. It plays an important regulatory role, and has important biological significance for the formation and development of embryonic nervous system, bone and blood vessels. As a potential carcinogenic factor, FGF17 is involved in the occurrence, development and metastasis of various cancers. It provides clues for studying the pathogenesis and treatment of cancer, such as the treatment of breast cancer and leukemia.
|
Product Name |
Recombinant FGF-17-V1 Protein |
|
Species |
Human |
|
Product Size |
10ug/100ug/1mg/5mg |
|
Gene sequence and source |
|
|
Gene construction and expression |
Full human Fgf17 (variant 1) CDS was expressed in E.Coli. |
|
Fusion Tag |
6x His-SUMO (N-terminus) |
|
Molecular Weight |
A |
|
Purity |
>97% by SDS-PAGE |
|
Physical property |
Lyophilized powder |
|
Reconstitution |
Prepare10×stock solution（4 mg/mL），aliquot and store at-20℃。 |
|
Stock solution |
Lyophilized powder can be resolved in sterile PBS or relevant resolvent. Working solutions: according to the experimental requirement dilute the stock solution for immediate use. |
|
|
Reference
